Looking to Profit From the Artemis II Mission? Buy RocketLab and AeroVironment Stocks.

The article is constructive on Rocket Lab and AeroVironment, highlighting strong operating momentum, large backlog growth, and favorable analyst ratings. Rocket Lab reported Q4 2025 revenue of $179.7 million, up 35.7% year over year, with full-year 2025 revenue of $602 million and a record $1.85 billion backlog; AeroVironment posted Q3 fiscal 2026 revenue of $408.0 million, up 143.3%, and raised funded backlog to $1.1 billion. Both stocks are presented as beneficiaries of rising defense and space spending, with analyst upside targets of 24% for RKLB and 64.6% for AVAV.

Analysis

The market’s real signal here is not “space is hot,” but that the capital-light, high-iteration model is beginning to outrun the legacy prime-contractor model. RKLB’s edge is that every successful launch and satellite-system win compounds credibility with both commercial constellations and government buyers, which should keep backlog quality improving even if headline margins compress during Neutron buildout. That makes the stock more of a growth-duration asset than a pure aerospace cyclical, and explains why dips tied to macro or sector tape have been bid aggressively.

AVAV is a different animal: the BlueHalo acquisition broadens the revenue base, but it also raises integration and cash-conversion risk just as the market is paying for “platform” optionality. The key second-order effect is procurement mix: as defense budgets tilt toward autonomous systems, counter-drone, and space/cyber convergence, AVAV can win share even without a clean quarterly beat. The problem is that investor positioning is already crowded enough that execution slippage or another timing-related miss can trigger outsized de-rating over days/weeks, not quarters.

The underappreciated loser is the older launch-and-defense industrial complex, where reputational wins from Artemis-style missions do not automatically translate into better economics. If reusability and software-defined payload integration become the true buying criteria, legacy primes may keep the top-line but lose margin mix to specialized vendors. That creates a good relative-value setup: the space theme is real, but the best expression is not beta to the whole group; it is selecting the firms with operating leverage to recurring demand and credible path to higher launch cadence or faster defense commercialization.

Key Decisions for Investors

• Long RKLB on 4-8 week pullbacks, targeting a re-rate toward consensus upside if management can keep Neutron milestones on schedule; downside is a sharp derate if development slips, so size as a growth catalyst trade rather than a core hold.
• Pair trade: long RKLB / short BA for 1-3 months. This isolates the market’s preference for agile space platforms over legacy execution risk, with BA acting as the weaker operational benchmark.
• Tactically buy AVAV only on post-volatility flushes or after confirmation that backlog-to-revenue conversion is stabilizing; upside remains meaningful over 6-12 months, but the entry point matters because cash burn and integration risk can compress multiple quickly.
• Use AVAV call spreads rather than outright equity for a 3-6 month horizon if expecting another defense-budget impulse; this captures upside from renewed sector rotation while limiting damage from another earnings gap-down.
• Avoid chasing LMT/BA on Artemis headlines; if anything, use them as funding shorts against RKLB or AVAV because the incremental thematic bid is likely to accrue to faster-moving platforms, not the incumbents.